0.5ZnO@Cu5.4O nanoparticle for regulates the expression of GSDMB and targeted therapy of tumor

Abstract GSDMB, a key protein in pyroptosis, is closely linked to various diseases. Nanomaterials can target and regulate specific pathways. Herein, we report a simple and efficient one-step method to develop multi-enzyme nanoparticles capable of suppressing GSDMB expression. 0.5ZnO@Cu5.4O can inhib...

Full description

Saved in:
Bibliographic Details
Main Authors: Hao Zhang, Guoyan Liu
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-025-03874-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849433141594292224
author Hao Zhang
Guoyan Liu
author_facet Hao Zhang
Guoyan Liu
author_sort Hao Zhang
collection DOAJ
description Abstract GSDMB, a key protein in pyroptosis, is closely linked to various diseases. Nanomaterials can target and regulate specific pathways. Herein, we report a simple and efficient one-step method to develop multi-enzyme nanoparticles capable of suppressing GSDMB expression. 0.5ZnO@Cu5.4O can inhibit GSDMB, a capability that neither ZnO nor Cu5.4O possesses. ZnO@Cu5.4O with different ratios also exhibits varying inhibitory effects. The 0.5ZnO@Cu5.4O can be cleared quickly in vivo, ensuring biocompatibility. Additionally, 0.5ZnO@Cu5.4O significantly inhibits tumor progression, offering promising avenues for clinical cancer therapy, and the development of gene-regulating nanoparticles.
format Article
id doaj-art-0e8ca5b3260447dc9aa294d3797e259e
institution Kabale University
issn 1475-2867
language English
publishDate 2025-06-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj-art-0e8ca5b3260447dc9aa294d3797e259e2025-08-20T03:27:10ZengBMCCancer Cell International1475-28672025-06-0125111010.1186/s12935-025-03874-z0.5ZnO@Cu5.4O nanoparticle for regulates the expression of GSDMB and targeted therapy of tumorHao Zhang0Guoyan Liu1Department of Gastrointestinal Surgery, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen UniversityDepartment of Gastrointestinal Surgery, Xiang’an Hospital of Xiamen University, School of Medicine, Xiamen UniversityAbstract GSDMB, a key protein in pyroptosis, is closely linked to various diseases. Nanomaterials can target and regulate specific pathways. Herein, we report a simple and efficient one-step method to develop multi-enzyme nanoparticles capable of suppressing GSDMB expression. 0.5ZnO@Cu5.4O can inhibit GSDMB, a capability that neither ZnO nor Cu5.4O possesses. ZnO@Cu5.4O with different ratios also exhibits varying inhibitory effects. The 0.5ZnO@Cu5.4O can be cleared quickly in vivo, ensuring biocompatibility. Additionally, 0.5ZnO@Cu5.4O significantly inhibits tumor progression, offering promising avenues for clinical cancer therapy, and the development of gene-regulating nanoparticles.https://doi.org/10.1186/s12935-025-03874-zGSDMBNanoparticlesTumor
spellingShingle Hao Zhang
Guoyan Liu
0.5ZnO@Cu5.4O nanoparticle for regulates the expression of GSDMB and targeted therapy of tumor
Cancer Cell International
GSDMB
Nanoparticles
Tumor
title 0.5ZnO@Cu5.4O nanoparticle for regulates the expression of GSDMB and targeted therapy of tumor
title_full 0.5ZnO@Cu5.4O nanoparticle for regulates the expression of GSDMB and targeted therapy of tumor
title_fullStr 0.5ZnO@Cu5.4O nanoparticle for regulates the expression of GSDMB and targeted therapy of tumor
title_full_unstemmed 0.5ZnO@Cu5.4O nanoparticle for regulates the expression of GSDMB and targeted therapy of tumor
title_short 0.5ZnO@Cu5.4O nanoparticle for regulates the expression of GSDMB and targeted therapy of tumor
title_sort 0 5zno cu5 4o nanoparticle for regulates the expression of gsdmb and targeted therapy of tumor
topic GSDMB
Nanoparticles
Tumor
url https://doi.org/10.1186/s12935-025-03874-z
work_keys_str_mv AT haozhang 05znocu54onanoparticleforregulatestheexpressionofgsdmbandtargetedtherapyoftumor
AT guoyanliu 05znocu54onanoparticleforregulatestheexpressionofgsdmbandtargetedtherapyoftumor